- Citations, last 5 years
- 2 490
- Works, last 5 years
- 440
- h-index
- 112
- Scientists listed
- 0
- Grants since 2016
- 3 213
Grants received
2021–2023 · research · R03
Understanding the Guideline-Discordant Use of Bone Modifying Agents in Prostate Cancer
Aaron P Mitchell · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Lipotoxic Protective Response of the Endoplasmic Reticulum
Robert V Farese · Kettering University · funded by National Institutes of Health
2021–2023 · research · R21
Proteomic Characterization of Pancreatic Neuroendocrine Tumors and Metastatic Progression
Michael H. A. Roehrl · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Directing fate, subtype identity and survival in human pluripotent-derived midbrain dopamine neurons
Doron Betel · Kettering University · funded by National Institutes of Health
2021–2023 · research · R21
Patient-derived organoids reveal rectal cancers develop radiosensitivity
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
Behavioral Activation for Depression in Older Adult Cancer Survivors: Pilot Randomized Control Trial and Implementation Outcomes
Rebecca Saracino · Kettering University · funded by National Institutes of Health
2021–2022 · research · R01
Image-guided Trp-IDO/TDO-Kyn-AHR pathway inhibition, combined with immunotherapy
Ronald George Blasberg · Kettering University · funded by National Institutes of Health
2021–2026 · cooperative agreement · U01
Deciphering the Genomics of Gene Network Regulation of T Cell and Fibroblast States in Autoimmune Inflammation
Christina S Leslie · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
A multi-faceted intervention to promote breast cancer hormone receptor testing in Tanzania
Dianna L. Ng · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
Emily H Cheng · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Meaning-Centered Grief Therapy for Parents Bereaved by Cancer: A Multisite Randomized Controlled Trial
Wendy G. Lichtenthal · Kettering University · funded by National Institutes of Health
2021–2024 · fellowship · F31
Deciphering the Role of Lysosomal Biogenesis in Anti-Aspergillus Immune Responses
Mariano Alejandro Aufiero · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Drivers of histologic transformation in EGFR-mutant lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
HCMV-induced innate-like CD8 T cells and allogeneic HCT outcome
Katharine C Hsu · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Development of multimodal agents from natural spider peptides for prostate cancer via sodium-channel NaV1.7
Junior Arturo Gonzales-Arevalo · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Characterizing and Targeting BAX- and BAK-Dependent Cell Death in Cancer
Emily H Cheng · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Mechanisms of lysosomal ion transport proteins involved in pH homeostasis
Richard Kevin Hite · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Selfish meiotic drive and the role of RNAi in defending intragenomic conflict
Jeffrey Vedanayagam · Kettering University · funded by National Institutes of Health
2021–2026 · training · T32
Molecular Imaging in Cancer Biology Training Program
Hedvig Hricak · Kettering University · funded by National Institutes of Health
2021–2025 · research · R01
Ceramide-Rich Platforms Functionalize Gemcitabine Uptake
Richard N Kolesnick · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Mechanistically Dissecting Glycolysis Regulation by Lactate and Its Therapeutic Potential in Cancer
Xin Cai · Kettering University · funded by National Institutes of Health
2021–2026 · research · R35
Sizing and Scaling in Functional Muscle Cells
Mary K Baylies · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Redox control of the NLRP1 inflammasome
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Adapting and Testing a Novel Self-Compassion Intervention to Reduce Lung Cancer Stigma
Timothy J Williamson · Kettering University · funded by National Institutes of Health
2021–2026 · career development · K08
Investigating the contribution of cellular senescence to the efficacy of radiation therapy.
Paul Bernard Romesser · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
Brett Stewart Carver · Kettering University · funded by National Institutes of Health
2021–2026 · research · R37
Interrogating the in vivo pharmacokinetics of armored CARs with radiohapten capture
Simone Krebs · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting immune suppressive microenvironment in ATC
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2026 · grant · DP2
Rethinking the "quiet" nature of apoptotic cell clearance.
Justin S Perry · Kettering University · funded by National Institutes of Health
2021–2023 · career development · K99
Investigating the metabolic regulation of tumor desmoplasia
Simon Schwörer · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Macrophages as modulators of T cell function and therapeutic response in clear cell renal cell carcinoma
Abraham Ari Hakimi · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Redox control of the NLRP1 inflammasome
Daniel Bachovchin · Kettering University · funded by National Institutes of Health
2021–2024 · research · R21
The mycobiota, bone marrow transplantation, and clinical outcomes
Tobias M Hohl · Kettering University · funded by National Institutes of Health
2021–2028 · research · R35
Novel therapeutic development for small cell lung cancer
Charles M. Rudin · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Targeting immune suppressive microenvironment in ATC
James A Fagin · Kettering University · funded by National Institutes of Health
2021–2023 · cooperative agreement · U01
Define the Role of POT1 Mutation in Genome Instability and Cancer
Agnel Sfeir · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
Predicting sensitivity and resistance in RET-driven cancers
Alexander Drilon · Kettering University · funded by National Institutes of Health
2021–2026 · research · R01
PSMA’s enzymatic activity as new target for Prostate Cancer diagnosis and therapy
Brett Stewart Carver · Kettering University · funded by National Institutes of Health
2021–2026 · research · R37
Molecular Pathogenesis and Therapy of Systemic Histiocytic Neoplasms
Eli Lous Diamond · Kettering University · funded by National Institutes of Health
2021–2024 · fellowship · F31
Genetic Determinants of Evolutionary Trajectories and Clinical Course in Pancreatic Cancer
Katelyn Mullen · Kettering University · funded by National Institutes of Health